L. S. St. John

发表

CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.

D. Couriel, R. Champlin, K. Komanduri, 2004, Blood.

CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis

R. Sidman, W. Arap, A. Corti, 2013, Proceedings of the National Academy of Sciences.

Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation

K. Clise-Dwyer, J. Molldrem, Qing Ma, 2018, The Journal of Immunology.

Neuropilin-1 mediates neutrophil elastase uptake and cross-presentation in breast cancer cells

S. Hanash, E. Mittendorf, C. Toniatti, 2017, The Journal of Biological Chemistry.

Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes

E. Shpall, E. Mittendorf, A. Philips, 2019, Clinical Cancer Research.

An anti-PR1/HLA-A2 T-cell receptor-like antibody mediates complement-dependent cytotoxicity against acute myeloid leukemia progenitor cells.

A. Sergeeva, K. Clise-Dwyer, B. McIntyre, 2011, Blood.

Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing.

E. Shpall, L. Worth, R. Champlin, 2007, Blood.

The Role of Antigen Cross-presentation From Leukemia Blasts on Immunity to the Leukemia-associated Antigen PR1

G. Lizée, E. Mittendorf, S. Liang, 2012, Journal of immunotherapy.

Breast cancer cell uptake of the inflammatory mediator neutrophil elastase triggers an anticancer adaptive immune response.

Yun Wu, E. Mittendorf, A. Philips, 2012, Cancer research.

Vitamin D receptor upregulation in alloreactive human T cells.

U. Popat, R. Joseph, K. Komanduri, 2012, Human immunology.

Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units

S. Karandish, D. Couriel, R. Champlin, 2002, British journal of haematology.

A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2

A. Sergeeva, K. Clise-Dwyer, Dongxing Zha, 2019, Front. Immunol..

Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes.

D. Kontoyiannis, K. Komanduri, E. Orciuolo, 2005, Blood.

Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells.

S. Rowland-Jones, R. Champlin, K. Komanduri, 2002, Blood.

Ex vivo expanded umbilical cord blood T cells maintain naive phenotype and TCR diversity.

S. Parmar, E. Shpall, W. Decker, 2006, Cytotherapy.

Broad Cross-Presentation of the Hematopoietically Derived PR1 Antigen on Solid Tumors Leads to Susceptibility to PR1-Targeted Immunotherapy

Yun Wu, P. Hwu, E. Mittendorf, 2012, The Journal of Immunology.

Functional assessment and specific depletion of alloreactive human T cells using flow cytometry.

R. Champlin, K. Komanduri, J. Mcmannis, 2004, Blood.

A role for BMP-induced homeobox gene MIXL1 in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy

M. Guindani, B. Liu, S. Liang, 2014, Oncotarget.

Common Minor Histocompatibility Antigen Discovery Based upon Patient Clinical Outcomes and Genomic Data

J. Falkenburg, S. Liang, S. Hunsucker, 2011, PloS one.

A Novel HLA-A*0201 Restricted Peptide Derived from Cathepsin G Is an Effective Immunotherapeutic Target in Acute Myeloid Leukemia

G. Lizée, E. Mittendorf, Zein Al-Atrache, 2012, Clinical Cancer Research.

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.

H. Andersson, S. Forman, L. Cooper, 2011, Blood.

Decreases in thymopoiesis of astronauts returning from space flight.

D. Pierson, K. Komanduri, B. Crucian, 2016, JCI insight.

Human Late Memory CD8+ T Cells Have a Distinct Cytokine Signature Characterized by CC Chemokine Production without IL-2 Production1

K. Komanduri, J. Khalili, Jahan S Khalili, 2009, The Journal of Immunology.

Targeting the Leukemia Antigen PR1 with Immunotherapy for the Treatment of Multiple Myeloma

E. Mittendorf, K. Young, A. Philips, 2018, Clinical Cancer Research.

Two unique HLA-A*0201 restricted peptides derived from cyclin E as immunotherapeutic targets in leukemia

K. Ishiyama, K. Clise-Dwyer, N. Qiao, 2020, Leukemia.

Activity of 8F4, a T cell receptor-like anti-PR1/HLA-A2 antibody, against primary human AML in vivo

Jeffrey J. Molldrem, M. J. You, A. Sergeeva, 2016, Leukemia.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

S. Hanash, J. Roth, S. Swisher, 2017, Cancer immunology research.

Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.

Z. Chen, K. Adler‐Storthz, E. Shillitoe, 1996, Cancer gene therapy.

PR1-specific cytotoxic T lymphocytes are relatively frequent in umbilical cord blood and can be effectively expanded to target myeloid leukemia.

K. Rezvani, E. Shpall, C. Bollard, 2016, Cytotherapy.

Serine Proteases Enhance Immunogenic Antigen Presentation on Lung Cancer Cells

S. Hanash, J. Roth, S. Swisher, 2017, Cancer Immunology Research.

CD13-positive bone marrow-derived myeloid cells promote angiogenesis, tumor growth, and metastasis

R. Sidman, W. Arap, A. Corti, 2013, Proceedings of the National Academy of Sciences.

Characterization of immunologic properties of a second HLA-A2 epitope from a granule protease in CML patients and HLA-A2 transgenic mice.

H. Andersson, S. Forman, L. Cooper, 2011, Blood.